Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...

The following is a summary of "Prognosis of distal segment reflux after proximal segment treatment of an incompetent small ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

The following is a summary of "12-month outcomes of pulsed-field ablation with a variable-diameter circular catheter for ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Aggressive ablation shows better clinical outcomes than regular ablation in patients with persistent atrial fibrillation.

St. David's in Austin is the first in country to use new dual catheter to fix heart flutter and AFib at the same time.

such as endothermal ablation and foam sclerotherapy Surgery to remove varicose veins Compression stockings Treatment to improve how varicose veins look is not usually available on the NHS if they ...